The Latest Breaking News from Haleon

Sanofi SA (NASDAQ: SNY), GSK Plc (NYSE: GSK), and Haleon Plc (NYSE: HLN) have lost a combined $40 billion in mar

Pharmaceutical stocks GSK, Sanofi and Haleon extended deep losses Thursday amid looming litigation around recalled heartburn drug Zantac.

Consumer health company ends first day on London Stock Exchange with £28.5bn market valuation

Consumer healthcare business Haleon makes its debut on the London stock market today after completing its demerger from GSK.

Close on the heels of an M&A deal, GlaxoSmithKline plc (NYSE: GSK) confirmed the spin-off of the consumer healthcare business it jointly owns with U.S. pharma giant Pfizer, Inc.

Reuters Redbird Capital Buys Italian Football Club AC Milan

Pfizer Inc. (NYSE:PFE) intends to sell its 32% investment in Haleon, a consumer health joint venture with GSK plc (NYSE:GSK), after the business is spun out as an independent listed company in July, reported Reuters. Pfizer had previously indicated that it might seek to sell its stake in Haleon, a consumer health company and…

Oil is always a political business, and there’s no point pretending otherwise

Expected to be the biggest London listing in a decade, the Haleon demerger is scheduled for July